IGF1 and Parkinson disease: In keeping with this evidence, we reported a significant association between low serum IGF-1 levels and poor performances on executive tasks at PD diagnosis and on attention/executive and verbal memory tasks after two-years since diagnosis in a cohort of 65 drug-naïve, early patients, suggesting a link between IGF-1 and early cognitive impairment in PD [14].